These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33385285)

  • 21. Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings.
    Seifert BA; O'Daniel JM; Amin K; Marchuk DS; Patel NM; Parker JS; Hoyle AP; Mose LE; Marron A; Hayward MC; Bizon C; Wilhelmsen KC; Evans JP; Earp HS; Sharpless NE; Hayes DN; Berg JS
    Clin Cancer Res; 2016 Aug; 22(16):4087-4094. PubMed ID: 27083775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
    Rasnic R; Brandes N; Zuk O; Linial M
    BMC Cancer; 2019 Aug; 19(1):783. PubMed ID: 31391007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germline mutations in lung cancer.
    Shukuya T; Takahashi K
    Respir Investig; 2019 May; 57(3):201-206. PubMed ID: 30639082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma.
    Carlo MI; Mukherjee S; Mandelker D; Vijai J; Kemel Y; Zhang L; Knezevic A; Patil S; Ceyhan-Birsoy O; Huang KC; Redzematovic A; Coskey DT; Stewart C; Pradhan N; Arnold AG; Hakimi AA; Chen YB; Coleman JA; Hyman DM; Ladanyi M; Cadoo KA; Walsh MF; Stadler ZK; Lee CH; Feldman DR; Voss MH; Robson M; Motzer RJ; Offit K
    JAMA Oncol; 2018 Sep; 4(9):1228-1235. PubMed ID: 29978187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hereditary cancer syndromes].
    Gerdes AM
    Ugeskr Laeger; 2011 Aug; 173(34):2035-8. PubMed ID: 21867655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The emerging significance of secondary germline testing in cancer genomics.
    Mandelker D; Zhang L
    J Pathol; 2018 Apr; 244(5):610-615. PubMed ID: 29293272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RB1 gene mutations in Argentine retinoblastoma patients. Implications for genetic counseling.
    Parma D; Ferrer M; Luce L; Giliberto F; Szijan I
    PLoS One; 2017; 12(12):e0189736. PubMed ID: 29261756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.
    Lee DS; Yoon SY; Looi LM; Kang P; Kang IN; Sivanandan K; Ariffin H; Thong MK; Chin KF; Mohd Taib NA; Yip CH; Teo SH
    Breast Cancer Res; 2012 Apr; 14(2):R66. PubMed ID: 22507745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic Predisposition to Neonatal Tumors.
    Quinn E; McGee R; Nuccio R; Pappo AS; Nichols KE
    Curr Pediatr Rev; 2015; 11(3):164-78. PubMed ID: 26168939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spectrum of PALB2 germline mutations and characteristics of PALB2-related breast cancer: Screening of 16,501 unselected patients with breast cancer and 5890 controls by next-generation sequencing.
    Zhou J; Wang H; Fu F; Li Z; Feng Q; Wu W; Liu Y; Wang C; Chen Y
    Cancer; 2020 Jul; 126(14):3202-3208. PubMed ID: 32339256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of germline genetic mutations in patients with pancreatic cancer.
    Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
    Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced sensitivity for detection of low-level germline mosaic RB1 mutations in sporadic retinoblastoma cases using deep semiconductor sequencing.
    Chen Z; Moran K; Richards-Yutz J; Toorens E; Gerhart D; Ganguly T; Shields CL; Ganguly A
    Hum Mutat; 2014 Mar; 35(3):384-91. PubMed ID: 24282159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of three new mutations in the RB1 gene in patients with sporadic retinoblastoma in Colombia.
    Serrano ML; Yunis JJ
    Biomedica; 2013; 33(1):53-61. PubMed ID: 23715307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Germline Mutations in Predisposition Genes in Pediatric Cancer.
    Zhang J; Walsh MF; Wu G; Edmonson MN; Gruber TA; Easton J; Hedges D; Ma X; Zhou X; Yergeau DA; Wilkinson MR; Vadodaria B; Chen X; McGee RB; Hines-Dowell S; Nuccio R; Quinn E; Shurtleff SA; Rusch M; Patel A; Becksfort JB; Wang S; Weaver MS; Ding L; Mardis ER; Wilson RK; Gajjar A; Ellison DW; Pappo AS; Pui CH; Nichols KE; Downing JR
    N Engl J Med; 2015 Dec; 373(24):2336-2346. PubMed ID: 26580448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma.
    Salviat F; Gauthier-Villars M; Carton M; Cassoux N; Lumbroso-Le Rouic L; Dehainault C; Levy C; Golmard L; Aerts I; Doz F; Bonnet-Serrano F; Hayek S; Savignoni A; Stoppa-Lyonnet D; Houdayer C
    JAMA Ophthalmol; 2020 Aug; 138(8):843-850. PubMed ID: 32556071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Monoallelic germline methylation and sequence variant in the promoter of the RB1 gene: a possible constitutive epimutation in hereditary retinoblastoma".
    Quiñonez-Silva G; Dávalos-Salas M; Recillas-Targa F; Ostrosky-Wegman P; Aranda DA; Benítez-Bribiesca L
    Clin Epigenetics; 2016; 8():1. PubMed ID: 26753011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Next generation sequencing of RB1gene for the molecular diagnosis of ethnic minority with retinoblastoma in Yunnan.
    Zhang Z; Xiao YS; Shen R; Jiang HC; Tan L; Li RQ; Yang XH; Gu HY; He WJ; Ma J
    BMC Med Genet; 2020 Nov; 21(1):230. PubMed ID: 33225895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knudson's hypothesis revisited in Indian retinoblastoma patients.
    Gaikwad N; Vanniarajan A; Husain A; Jeyaram I; Thirumalairaj K; Santhi R; Muthukkaruppan V; Kim U
    Asia Pac J Clin Oncol; 2015 Dec; 11(4):299-307. PubMed ID: 26264229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of TP53 pathogenic variants in early-onset HER2-positive breast cancer.
    Escudeiro C; Pinto C; Vieira J; Peixoto A; Pinto P; Pinheiro M; Santos C; Guerra J; Lisboa S; Santos R; Silva J; Leal C; Coimbra N; Lopes P; Ferreira M; Sousa AB; Teixeira MR
    Fam Cancer; 2021 Jul; 20(3):173-180. PubMed ID: 33051812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria.
    Hoyer J; Vasileiou G; Uebe S; Wunderle M; Kraus C; Fasching PA; Thiel CT; Hartmann A; Beckmann MW; Lux MP; Reis A
    BMC Cancer; 2018 Sep; 18(1):926. PubMed ID: 30257646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.